Using evidence-based guideline for prophylactic platelet transfusion in patient with myelodysplastic syndrome

Chinese Journal of Evidence-Based Medicine

Volumn 5, Issue 6, 2005, Pages 482-484

  Wang, Xiao Qin ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Evidence based guideline; Myelodysplastic syndrome; Prophylactic platelet transfusion

Indexed keywords

THROMBOCYTE CONCENTRATE;

CLINICAL TRIAL; EVIDENCE BASED MEDICINE; HUMAN; MEDICAL DECISION MAKING; MEDLINE; MYELODYSPLASTIC SYNDROME; PRACTICE GUIDELINE; PROPHYLAXIS; REVIEW; THROMBOCYTE TRANSFUSION; TREATMENT INDICATION;

EID: 21644448081     PISSN: 16722531     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (4)

1. British Committee for Standards in Haematology, Blood Transfusion Task Force. Guidelines for the use of platelet transfusions[J]. Br J Haematol, 2003; 122(1): 10-23.
2. Schiffer CA, Anderson KC, Bennett CL, Bernstein S, Elting LS, Goldsmith M, Goldstein M, Hume H, McCullough JJ, McIntyre RE, Powell BL, Rainey JM, Rowley SD, Rebulla P, Troner MB, Wagnon AH; American Society of Clinical Oncology. Platelet transfusion for patients with cancer; clinical practice guidelines of the American Society of Clinical Oncology[J]. J Clin Oncol, 2001; 19 (5); 1519-1538.
3. Hayward RS, Wilson MC, Tunis SR, Bass EB, Guyatt G. Users' guides to the medical literature. VIII. How to use clinical practice guidelines. A. Are the recommendations valid[J]. JAMA, 1995; 274(7): 570-574.
4. Wilson MC, Hayward RS, Tunis SR, Bass EB, Guyatt G. Users' guides to the medical literature. VIII. How to use clinical practice guidelines. B. What are the recommendations, and will they help you in caring for your patients[J]. JAMA, 1995; 274(20): 1630 -1632.